# WGS Analysis of COVID-19 Positive Patients

> **NCT04353401** · — · COMPLETED · sponsor: **Vanda Pharmaceuticals** · enrollment: 79 (actual)

## Conditions studied

- Coronavirus Infection
- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04353401
- **Lead sponsor:** Vanda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-03
- **Primary completion:** 2022-03-09
- **Final completion:** 2022-03-09
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2024-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04353401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04353401, "WGS Analysis of COVID-19 Positive Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04353401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*